A Thread On ANG 🧵
 
ANG Lifescience Ltd

Cmp 316

Market cap :164 cr

Promoter holding :71%

Public : 29%

ROCE :23.7%

ROE : 20.4%

Book value :66.7
 
Management has given Revenue Guidance of 350 Cr in current financial but confident to post 450 to 500 Cr Revenue in Current FY

Company will post In H1
________________________

*Topline 240 Cr

Ebidta 25 Cr,

NP 18 Cr,

EPS 36 Rs*

Which will be 600% Rise in Profit YoY.

Current FY
____________

*Total Revenue  >>> 450- 500 Cr

EBIDTA >>>> 45 Cr

NP >>> 35 Cr

EPS >>> 70 Rs.*

Stock can see 4 digit  in next 10 to 12 month or Current FY.

ANG life science has 3 injectable units which is spread in 4500 Sq mtr & 11k Sq Mtr area at Baddi and 1 OSD unit ( Oral Solid Dosage).One injectable unit is under commissioning which will be operational in Dec 2021.

ANG life science India ltd ,incorporated in the year 2006 at Baddi  is engaged in the business of Manufacturing and Marketing of finished Pharmaceutical  Formulation in a Dosage form of Sterile Dry Powder Injection Vial.

The company products portfolio include *100 plus product comprising major Therapeutic categories such as Cephalosporin’s Antibiotic( Generation I,II,III,IV),Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid , Penicillin & B Lactamases Inhibitor.